TY - JOUR
T1 - Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphoma
AU - Mclaughlin, Peter
AU - Velasquez, William S.
AU - Redman, John R.
AU - Yung, W. k.Alfred
AU - Hagemeister, Fredrick B.
AU - Rodriguez, Maria A.
AU - Cabanillas, Fernando
N1 - Copyright:
Copyright 2010 Elsevier B.V., All rights reserved.
PY - 1988/2/2
Y1 - 1988/2/2
N2 - Ten Patients with parenchymal CNS lymphoma received combination che-motherapy with dexamethasone, high-dose cytarabine, and cisplatin(DHAP), and additional therapy according toclinical circumstances. Two of four patients with primary CNS lym-phoma achieved and remain in completeremission (CR). Four of six patients with CNS lymphoma at relapse also achieved CR. DHAP is activeagainst CNS lymphoma. Flurther trials with DHAP, Particularly in conjunction with other treatment modalities, are warranted. [J Natl Cancer Inst 1988;80:1408-1412].
AB - Ten Patients with parenchymal CNS lymphoma received combination che-motherapy with dexamethasone, high-dose cytarabine, and cisplatin(DHAP), and additional therapy according toclinical circumstances. Two of four patients with primary CNS lym-phoma achieved and remain in completeremission (CR). Four of six patients with CNS lymphoma at relapse also achieved CR. DHAP is activeagainst CNS lymphoma. Flurther trials with DHAP, Particularly in conjunction with other treatment modalities, are warranted. [J Natl Cancer Inst 1988;80:1408-1412].
UR - http://www.scopus.com/inward/record.url?scp=0023699931&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023699931&partnerID=8YFLogxK
U2 - 10.1093/jnci/80.17.1408
DO - 10.1093/jnci/80.17.1408
M3 - Article
C2 - 3172268
AN - SCOPUS:0023699931
SN - 0027-8874
VL - 80
SP - 1408
EP - 1412
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 17
ER -